Movano is in the development-stage and is developing a platform to deliver purpose-driven healthcare solutions at the intersection of medical and consumer devices. Co.'s solutions are being developed to provide vital health information, including heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, calories as well as glucose and blood pressure data, in a variety of form factors. Co.'s initial commercial product in development is the Evie Ring, which is a wearable designed specifically for women. Co. is also developing a small proprietary System-on-a-Chip designed specifically for blood pressure or continuous glucose monitoring systems. The MOVE stock yearly return is shown above.
The yearly return on the MOVE stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the MOVE annual return calculation with any dividends reinvested as applicable (on ex-dates).
|